Atlas Trials

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers

Clinical trial NCT03609294 · COMPLETED

Trial details

NCT number
NCT03609294
Sponsor
Boryung Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HypertensionDiabetes
Start date
2018-07-18
Primary completion
2019-03-04
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.